Information Exploration System for Sickle Cell Disease and Repurposing of Hydroxyfasudil
KAUST DepartmentComputational Bioscience Research Center (CBRC)
Computer, Electrical and Mathematical Sciences and Engineering (CEMSE) Division
Permanent link to this recordhttp://hdl.handle.net/10754/325316
MetadataShow full item record
AbstractBackground:Sickle cell disease (SCD) is a fatal monogenic disorder with no effective cure and thus high rates of morbidity and sequelae. Efforts toward discovery of disease modifying drugs and curative strategies can be augmented by leveraging the plethora of information contained in available biomedical literature. To facilitate research in this direction we have developed a resource, Dragon Exploration System for Sickle Cell Disease (DESSCD) (http://cbrc.kaust.edu.sa/desscd/) that aims to promote the easy exploration of SCD-related data.Description:The Dragon Exploration System (DES), developed based on text mining and complemented by data mining, processed 419,612 MEDLINE abstracts retrieved from a PubMed query using SCD-related keywords. The processed SCD-related data has been made available via the DESSCD web query interface that enables: a/information retrieval using specified concepts, keywords and phrases, and b/the generation of inferred association networks and hypotheses. The usefulness of the system is demonstrated by: a/reproducing a known scientific fact, the "Sickle_Cell_Anemia-Hydroxyurea" association, and b/generating novel and plausible "Sickle_Cell_Anemia-Hydroxyfasudil" hypothesis. A PCT patent (PCT/US12/55042) has been filed for the latter drug repurposing for SCD treatment.Conclusion:We developed the DESSCD resource dedicated to exploration of text-mined and data-mined information about SCD. No similar SCD-related resource exists. Thus, we anticipate that DESSCD will serve as a valuable tool for physicians and researchers interested in SCD. © 2013 Essack et al.
CitationEssack M, Radovanovic A, Bajic VB (2013) Information Exploration System for Sickle Cell Disease and Repurposing of Hydroxyfasudil. PLoS ONE 8: e65190. doi:10.1371/journal.pone.0065190.
PublisherPublic Library of Science (PLoS)
PubMed Central IDPMC3677893
- Dragon exploratory system on hepatitis C virus (DESHCV).
- Authors: Kwofie SK, Radovanovic A, Sundararajan VS, Maqungo M, Christoffels A, Bajic VB
- Issue date: 2011 Jun
- Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors.
- Authors: Okam MM, Ebert BL
- Issue date: 2012 Jun
- Hydroxyurea for children with sickle cell disease.
- Authors: Heeney MM, Ware RE
- Issue date: 2008 Apr
- Hydroxyurea therapy in children severely affected with sickle cell disease.
- Authors: Scott JP, Hillery CA, Brown ER, Misiewicz V, Labotka RJ
- Issue date: 1996 Jun
- Advances in sickle cell disease treatment: from drug discovery until the patient monitoring.
- Authors: dos Santos JL, Lanaro C, Chin CM
- Issue date: 2011 Apr 1
Showing items related by title, author, creator and subject.
Security Strategies of Both Players in Asymmetric Information Zero-Sum Stochastic Games with an Informed ControllerLi, Lichun; Langbort, Cedric; Shamma, Jeff S. (arXiv, 2017-11-07) [Preprint]This paper considers a zero-sum two-player asymmetric information stochastic game where only one player knows the system state, and the transition law is controlled by the informed player only. For the informed player, it has been shown that the security strategy only depends on the belief and the current stage. We provide LP formulations whose size is only linear in the size of the uninformed player's action set to compute both history based and belief based security strategies. For the uninformed player, we focus on the regret, the difference between 0 and the future payoff guaranteed by the uninformed player in every possible state. Regret is a real vector of the same size as the belief, and depends only on the action of the informed player and the strategy of the uninformed player. This paper shows that the uninformed player has a security strategy that only depends on the regret and the current stage. LP formulations are then given to compute the history based security strategy, the regret at every stage, and the regret based security strategy. The size of the LP formulations are again linear in the size of the uninformed player action set. Finally, an intrusion detection problem is studied to demonstrate the main results in this paper.
OligoPVP: Phenotype-driven analysis of individual genomic information to prioritize oligogenic disease variantsBoudellioua, Imene; Kulmanov, Maxat; Schofield, Paul N.; Gkoutos, Georgios V.; Hoehndorf, Robert (Scientific Reports, Springer Nature America, Inc, 2018-09-26) [Article]An increasing number of disorders have been identified for which two or more distinct alleles in two or more genes are required to either cause the disease or to significantly modify its onset, severity or phenotype. It is difficult to discover such interactions using existing approaches. The purpose of our work is to develop and evaluate a system that can identify combinations of alleles underlying digenic and oligogenic diseases in individual whole exome or whole genome sequences. Information that links patient phenotypes to databases of gene–phenotype associations observed in clinical or non-human model organism research can provide useful information and improve variant prioritization for genetic diseases. Additional background knowledge about interactions between genes can be utilized to identify sets of variants in different genes in the same individual which may then contribute to the overall disease phenotype. We have developed OligoPVP, an algorithm that can be used to prioritize causative combinations of variants in digenic and oligogenic diseases, using whole exome or whole genome sequences together with patient phenotypes as input. We demonstrate that OligoPVP has significantly improved performance when compared to state of the art pathogenicity detection methods in the case of digenic diseases. Our results show that OligoPVP can efficiently prioritize sets of variants in digenic diseases using a phenotype-driven approach and identify etiologically important variants in whole genomes. OligoPVP naturally extends to oligogenic disease involving interactions between variants in two or more genes. It can be applied to the identification of multiple interacting candidate variants contributing to phenotype, where the action of modifier genes is suspected from pedigree analysis or failure of traditional causative variant identification.
OPA2Vec: combining formal and informal content of biomedical ontologies to improve similarity-based predictionSmaili, Fatima Z.; Gao, Xin; Hoehndorf, Robert (Bioinformatics, Oxford University Press (OUP), 2018-11-07) [Article]Motivation:Ontologies are widely used in biology for data annotation, integration, and analysis. In addition to formally structured axioms, ontologies contain meta-data in the form of annotation axioms which provide valuable pieces of information that characterize ontology classes. Annotation axioms commonly used in ontologies include class labels, descriptions, or synonyms. Despite being a rich source of semantic information, the ontology meta-data are generally unexploited by ontology-based analysis methods such. Results:We propose a novel method, OPA2Vec, to generate vector representations of biological entities in ontologies by combining formal ontology axioms and annotation axioms from the ontology metadata. We apply a Word2Vec model that has been pre-trained on either a corpus or abstracts or full-text articles to produce feature vectors from our collected data. We validate our method in two different ways: first, we use the obtained vector representations of proteins in a similarity measure to predict protein-protein interaction on two different datasets. Second, we evaluate our method on predicting gene-disease associations based on phenotype similarity by generating vector representations of genes and diseases using a phenotype ontology, and applying the obtained vectors to predict gene-disease associations using mouse model phenotypes. We demonstrate that OPA2Vec significantly outperforms existing methods for predicting gene-disease associations. Using evidence from mouse models, we apply OPA2Vec to identify candidate genes for several thousand rare and orphan diseases. OPA2Vec can be used to produce vector representations of any biomedical entity given any type of biomedical ontology. Availability:https://github.com/bio-ontology-research-group/opa2vec.